Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study

Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study

Background and Objectives: Intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute ischemic stroke (AIS) within 3 h after onset and the treatment was then extended to 4.5 h. However, the Food and Drug Administration did not approve the indication in the expanded time...

Full description

Bibliographic Details
Main Authors: Yu-Wei Chen, Sheng-Feng Sung, Chih-Hung Chen, Sung-Chun Tang, Li-Kai Tsai, Huey-Juan Lin, Hung-Yu Huang, Helen L. Po, Yu Sun, Po-Lin Chen, Lung Chan, Cheng-Yu Wei, Jiunn-Tay Lee, Cheng-Yang Hsieh, Yung-Yang Lin, Shoou-Jeng Yeh, Li-Ming Lien, Jiann-Shing Jeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Neurology
Subjects:
acute ischemic stroke
tissue plasminogen activator
intravenous thrombolysis
3–4.5 h after stroke onset
functional recovery
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.01038/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.01038/full

Similar Items